Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For IFX.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -2.45 1.80 1.84
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 64.19 5.71 3.48
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value -6.80 12.32 13.22
Cash -4.27 1.99 2.08
Capex 0.87 -0.50 -0.50
Free Cash Flow -87.31 0.08 -0.61
Revenue -1.39 2.80 2.84
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -10.50 0.39 0.43
Operating Margin -21.45 0.15 0.19
ROA -34.54 0.01 0.02
ROE -27.61 0.02 0.03
ROIC -24.29 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of IFX.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of IFX.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of IFX.DE is permitted for members.